Trials / Completed
CompletedNCT00561002
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine
Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2007-2008 Formulation)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
- Sex
- All
- Age
- 6 Months – 35 Months
- Healthy volunteers
- Accepted
Summary
To provide Centers for Biologic Evaluation and Research (CBER) with sera collected from healthy children receiving the 2007-2008 formulation of the inactivated, split-virion influenza vaccine Fluzone® for further study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 2007-2008 Influenza Virus Vaccine | 0.25 mL, Intramuscular |
| BIOLOGICAL | 2007-2008 Influenza Virus Vaccine | 0.25 mL, Intramuscular |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-05-01
- Completion
- 2008-06-01
- First posted
- 2007-11-20
- Last updated
- 2016-04-14
- Results posted
- 2009-08-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00561002. Inclusion in this directory is not an endorsement.